Retractable Technologies, Inc. (NYSE American: RVP) announced its financial results for the year ended December 31, 2025, revealing a significant revenue increase of 15.8%, amounting to approximately $38.3 million compared to $33.0 million in the previous year. This growth was driven by a 9.7% rise in domestic revenues, primarily due to increased sales of the VanishPoint® and EasyPoint® needle products. Notably, international revenues surged by 64.0%, largely attributed to higher sales of EasyPoint® needles. However, the company faced challenges with high operating costs, totaling $21.2 million, which resulted in a loss from operations of $21.2 million, slightly higher than the previous year's loss of $21.1 million. The net decrease in cash for 2025 was $1.6 million, leaving the company with a cash position of $2.6 million at year-end, alongside $34.4 million in debt and equity securities. Additionally, the company declared dividends for its Series II and Series III Class B Convertible Preferred Stock shareholders, amounting to $39,050.00 and $18,561.25, respectively, covering the period from January 1, 2026, to March 31, 2026, with payment scheduled for April 20, 2026. The dividends reflect the company's commitment to returning value to its shareholders despite the operational challenges it faces due to tariffs and increased production costs. As the company navigates these challenges, it remains focused on its strategic outlook and operational execution to enhance its market position.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.